Tavo-301/303

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameTavo-301/303
Drug Alias Nameimmunosuppressive pathway-modulating multispecific antibody-based therapeutics (Tavotek Lab)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody
Mechanisms of ActionImmunostimulants
TargetsUpdating
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesTavotek Biotherapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTavotek Biotherapeutics
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A